LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
27 funds hold it · Insiders net selling
Net selling: insiders sold $1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 3, 2026
Financial period
First Quarter Fiscal Year 2027
Earnings per share
$1.37 expected
Revenue
Company release
Estimates as of Nov 9, 2026
EPS expected
$1.45 to $1.84
Revenue expected
3 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 3, 2026 | $1.56est. $1.37 | +13.96%beat | $1.67BCompany release | +5.0%from $1.59B |
| Jun 30, 2026Reported Aug 4, 2026 | $3.82est. $3.76 | +1.68%beat | $2.22BAlpha Vantage | +7.5%from $2.07B |
| Mar 31, 2026Reported Apr 30, 2026 | $2.72est. $2.60 | +4.45%beat | $1.95BSEC filing | +7.8%from $1.81B |
| Dec 31, 2025Reported Feb 3, 2026 | $1.59est. $1.36 | +16.81%beat | $1.71BSEC filing | +7.8%from $1.59B |
| Sep 30, 2025Reported Nov 4, 2025 | $1.51est. $1.25 | +20.80%beat | $1.59BSEC filing | +11.7%from $1.42B |
| Jun 30, 2025Reported Aug 5, 2025 | $3.55est. $3.50 | +1.43%beat | $2.07BAlpha Vantage | +6.2%from $1.94B |
| Mar 31, 2025Reported May 1, 2025 | $2.44est. $2.41 | +1.24%beat | $1.81BSEC filing | +4.9%from $1.73B |
| Dec 31, 2024Reported Jan 31, 2025 | $1.56est. $1.49 | +4.70%beat | $1.59BSEC filing | +13.1%from $1.41B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.71B | $1.95B | $2.22B | $1.67B |
| Cost of what it sold | $1.24B | $1.33B | $1.37B | $1.24B |
| Gross profit | $473.6M | $626.9M | $853.0M | $428.4M |
| What it spent | ||||
| Sales and admin | $267.5M | $267.4M | $306.7M | $254.9M |
| Total operating expenses | $265.2M | $267.4M | $306.7M | $254.9M |
| What was left | ||||
| Operating profit | $208.4M | $359.5M | $546.3M | $173.5M |
| Interest on debt | $27.7M | $27.3M | $28.9M | $27.1M |
| Profit before tax | $370.2M | $340.6M | $521.9M | $109.7M |
| Tax | $85.7M | $64.3M | $123.9M | $14.9M |
| Net profit | $284.6M | $276.3M | $398.1M | $94.8M |
| EBITDA | $524.9M | $465.8M | $635.3M | $212.3M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Form 4 Broadridge Financial Solutions: Robert N. Duelks (Director) For: 10 November By Investing.com
NeutralNov 13Southern Company announces pricing of equity units
NeutralNov 13Silver Lake funds complete a share sale, but First Advantage (FA) receives no proceeds.
NeutralNov 12Broadridge (BR) director Eileen K. Murray receives stock awards that vest immediately.
NeutralNov 12A 645-unit stock grant for Broadridge (BR) director Robert N. Duelks vests immediately.
Leans bullishNov 12Broadridge (BR) director Flowers receives 645 deferred stock units and 2,659 immediately vested options.
NeutralNov 12BROADRIDGE FINANCIAL SOLUTIONS, INC. Initial Statement of Beneficial Ownership
NeutralNov 12After exercising options, director Maura Markus sold 3,180 Broadridge (BR) shares.
NeutralNov 1234 macro signals shaping BR right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
